likviriton and Myocardial-Infarction

likviriton has been researched along with Myocardial-Infarction* in 1 studies

Other Studies

1 other study(ies) available for likviriton and Myocardial-Infarction

ArticleYear
Liquiritin Protects Against Cardiac Fibrosis After Myocardial Fibrosis After Myocardial Infarction by Inhibiting CCL5 Expression and the NF-κB Signaling Pathway [Letter].
    Drug design, development and therapy, 2023, Volume: 17

    Topics: Chemokine CCL5; Fibrosis; Humans; Myocardial Infarction; Myocardium; NF-kappa B; Signal Transduction

2023